Efficacy and safety of anticholinergic agents applied for day-time or night-time

Efficacy and safety of anticholinergic agents applied for day-time or night-time - Efficacy and safety of anticholinergic agents applied for day-time or night-time

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006420

Enrollment

100

Registered

2011-11-01

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

Detrusitor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with overactive bladder

Exclusion criteria

Exclusion criteria: 1.Urinary retention has occured through the latest 1 year. 2.Post voied residual urine volume is more than 100ml. 3.The treatment has been already done. 4.Patients have sleep disturbance. 5.Patients have irregular life styles. 6.Patients have inhibited diseases for the use of anticholinergic agents.

Design outcomes

Primary

Measure	Time frame
The presence of dry mouth induced by Detrusitol, an anticholinergic agent, applied for day-time or night-time will be investigated.	—

Countries

Japan

Contacts

Public ContactAkira Furuta

Jikei University School of Medicine Urology

a-furuta@jikei.ac.jp03-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026